Vanderbilt study adds to the mounting role for inflammatory signaling in obesity.

A compound developed by researchers at Vanderbilt University can improve early symptoms and delay progression of Huntington’s disease in a mouse model of the neurodegenerative disorder.

Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease.

Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.

While 12 million Americans are enrolled in health care networks through the Affordable Care Act’s (ACA) insurance marketplace, a recent study in the Journal of the American Medical Association (JAMA) raises concerns about patient access to specialists within these insurance plans.

Walter Chazin, Ph.D., director of the Vanderbilt Center for Structural Biology, is a recipient of a 2016 Fellow of the Biophysical Society award.

Data in sports concussion studies will continue to be disputed as long as the injuries are diagnosed by differing standards instead of universal guidelines, a Vanderbilt investigator concludes in a recent review.